Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and Dyslipidemia in morbidly obese patients who present for Bariatric surgery

Obesity Surgery

Volumn 24, Issue 6, 2014, Pages 927-935

  Mostaedi, Rouzbeh ^a   Lackey, Denise E ^b   Adams, Sean H ^b,c   Dada, Stephen A ^a   Hoda, Zahid A ^a   Ali, Mohamed R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b USDAWestern Human Nutrition Research Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bariatric surgery; Comorbidities; Diabetes mellitus; Dyslipidemia; Hypertension; Metabolic syndrome; Obesity; Pharmacotherapy

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; COMORBIDITY; CONSULTATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84901483396     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1196-z     Document Type: Article

References (43)

1. Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-7. PMID: 22253363.
2. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health. 2007;121(7):492-6. PMID: 17399752.
3. Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiologic reviews. 2007;29:6-28. PMID: 17510091.
4. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956-61.
5. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obes Res. 1998;6 Suppl 2:51S-209S. Epub 1998/11/14. PMID: 9813653.
6. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(11):933-49.
7. Tsai AG, Wadden TA. Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med. 2009;24(9):1073-9. PMID: 19562419.
8. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med. 2001;134(1):1-11. PMID: 11187414.
9. Svetkey LP, Stevens VJ, Brantley PJ, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA. 2008;299(10):1139-48. PMID: 18334689.
10. Digenio AG, Mancuso JP, Gerber RA, et al. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med. 2009;150(4):255-62. PMID: 19221377.
11. Ryan DH, Johnson WD, Myers VH, et al. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med. 2010;170(2):146-54. PMID: 20101009.
12. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-37. PMID: 15479938.
13. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-93. PMID: 15616203.
14. Pories WJ, MacDonald Jr KG, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55(2 Suppl):582S-5. PMID: 1733132.
15. Grundy SM, Brewer Jr HB, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8. PMID: 14744958.
16. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898-918. PMID: 16380542.
17. Bays HE. "Sick fat," metabolic disease, and atherosclerosis. Am J Med. 2009;122(1 Suppl):S26-37. PMID: 19110085.
18. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009;13:1-7. PMID: 19634296.
19. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010;2(3):180-93. PMID: 20923483.
20. Ho JS, Cannaday JJ, Barlow CE, et al. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol. 2008;102(6):689-92. PMID: 18773989.
21. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52. PMID: 16157765.
22. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203. PMID: 18945920.
23. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29(8):1963-72. PMID: 16873813.
24. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52. PMID: 14656957.
25. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-39. PMID: 15249516.
26. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421. Epub 2002/12/18. PMID: 12485966.
27. Standards of Medical Care in Diabetes-2012. Diabetes Care. 2012;35 Suppl 1:S11-63. Epub 2012/01/04. PMID: 22187469.
28. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. PMID: 19805654.
29. Campbell RK. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc (2003). 2009;49 Suppl 1:S3-9. Epub 2009/10/06. PMID: 19801365.
30. National Committee for Quality Assurance. The State of Health Care Quality 2011 [Internet]. Washington: National Committee for Quality Assurance; 2011 [cited 2012 April 30]. Available from: www.ncqa.org/LinkClick.aspx? fileticket=wmpxiKWVgP0%3d&tabid = 36.
31. Cheung BM, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443-53. PMID: 19375554.
32. Riedel AA, Heien H, Wogen J, et al. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy. 2007;27(8):1102-10. PMID: 17655510.
33. Riedel AA, Heien H, Wogen J, et al. Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen. Am J Manag Care. 2007;13(8):457-63. PMID: 17685826.
34. Bertoia ML, Waring ME, Gupta PS, et al. Implications of new hypertension guidelines in the United States. Hypertension. 2011;58(3):361-6. PMID: 21768528.
35. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49(1):69-75. PMID: 17159087.
36. Kjeldsen SE, Naditch-Brule L, Perlini S, et al. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens. 2008;26(10):2064-70. PMID: 18806632.
37. Egan BM, Zhao Y, Axon RN, et al. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124(9):1046-58. PMID: 21824920.
38. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States [Internet]. Atlanta: Centers for Disease Control and Prevention; 2011 [cited 2012 April 30]. Available from: www.cdc.gov/diabetes/pubs/pdf/ndfs- 2011.pdf.
39. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598-605. PMID: 19805653.
40. Kuklina EV, Yoon PW, Keenan NL. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA. 2009;302(19):2104-10. PMID: 19920234.
41. Bhan V, Yan RT, Leiter LA, et al. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients. Am J Cardiol. 2010;106(9):1270-6. PMID: 21029823.
42. Varela JE, Hinojosa MW, Nguyen NT. Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic centers. Obes Surg. 2008;18(10):1273-7. PMID: 18431609.
43. Cosson E, Hamo-Tchatchouang E, Banu I, et al. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients. Diabetes & metabolism. 2010;36(4):312-8. PMID: 20627649.